0000899243-19-023467.txt : 20190912 0000899243-19-023467.hdr.sgml : 20190912 20190912173520 ACCESSION NUMBER: 0000899243-19-023467 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190701 FILED AS OF DATE: 20190912 DATE AS OF CHANGE: 20190912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hecht Beth CENTRAL INDEX KEY: 0001652410 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38536 FILM NUMBER: 191091115 MAIL ADDRESS: STREET 1: C/O NEOS THERAPEUTICS, INC. STREET 2: 2940 N. HIGHWAY 360 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: STE 1800 CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 512-498-2670 MAIL ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: STE 1800 CITY: CHICAGO STATE: IL ZIP: 60601 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-07-01 2019-07-03 0 0001346302 XERIS PHARMACEUTICALS INC XERS 0001652410 Hecht Beth C/O XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 0 1 0 0 See Remarks Common Stock 3624 D On July 3, 2019, the reporting person filed a Form 4 which inadvertently reported that, following her purchase of the underlying stock, she directly owned 3,928 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 3,624 shares of common stock. Senior Vice President, General Counsel and Corporate Secretary /s/ Beth Hecht 2019-09-12